Results 171 to 180 of about 9,401 (220)

[Prevalence of Rumination Syndrome: Experience in Three Countries of the Working Group on Brain-Gut Disorders of the Latin American Society of Pediatric Gastroenterology, Hepatology and Nutrition (LASPGHAN)]. [PDF]

Acta Gastroenterol Latinoam
Velasco-Benítez CA, Rodríguez-López E, Velasco-Suárez DA, Ortiz-Rivera CJ, Játiva-Mariño E, Avendaño ARD, Martínez A.   +6 more
europepmc   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Hemorraghic skin syndrome associated with contact of Lonomia spp. caterpillar: First report from the Ecuadorian Amazon [PDF]

Biomedica
Calvopina M, Guamán-Charco E, Vélez J, Vélez B, González C.   +4 more
europepmc   +1 more source

Long‐term cardiovascular outcomes of immune checkpoint inhibitor‐related myocarditis: A large single‐centre analysis

ESC Heart Failure, Volume 12, Issue 2, Page 1237-1245, April 2025.
Abstract Aims Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse events.
Lorenzo Braghieri, Ahmad Gharaibeh, Lubika Nkashama, Abdelrahman Abushouk, Osama Abushawer, Amir Mehdizadeh‐Shrifi, Bianca Honnekeri, Cassandra Calabrese, Venu Menon, Pauline Funchain, Patrick Collier, Diego Sadler, Rohit Moudgil   +12 more
wiley   +1 more source

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

ESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad, Jeanne du Fay de Lavallaz, Michael J. Zhang, Thanat Chaikijurajai, Bo Ye, Prabhjot S. Nijjar, Julie A. Lahiri, Cindy M. Martin, Tamas Alexy, Markus Meyer   +9 more
wiley   +1 more source

Masa oculta: reto diagnóstico en una adolescente con dolor abdominal agudo. [PDF]

Acta Gastroenterol Latinoam
Loaiza Pacheco I, Rodríguez De la Hoz DM, Laguna Kirof M, Larrañaga N, Orozco E.   +4 more
europepmc   +1 more source

Náusea y vómito postoperatorio en pacientes sometidos a cirugía de mama

Revista Chilena de Anestesia, 2019
Giancarlo Ferretiz G., Neftalí Cárdenas   +1 more
doaj   +1 more source

[Usefulness of spontaneous drawing in the diagnostic guidance of pediatric patients with headache]. [PDF]

Rev Neurol
García-Ron A, Arias-Vivas E, Bote-Gascón M, González-García N, Porta-Etessam J.   +4 more
europepmc   +1 more source

Exploring the efficacy and safety of perampanel in epilepsia partialis continua: A case series

Epileptic Disorders, EarlyView.
Abstract Background Epilepsia partialis continua (EPC) is a form of focal motor status epilepticus (SE), which is commonly drug‐resistant requiring treatment with multiple antiseizure medications (ASM). There are no established guidelines for pharmacological management.
Setareh Lahsaee, Kristin M. Ikeda, Stephanie Woodroffe, Benjamin P. Whatley   +3 more
wiley   +1 more source

[Arthritis secondary to tirzepatide. Case report]. [PDF]

Aten Primaria
Martín Correa E, Barceló Colomer ME, Martín Morata E.   +2 more
europepmc   +1 more source